17-phosphorous steroid derivatives useful as progesterone receptor modulators

Details for Australian Patent Application No. 2007217095 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Jiang, Weiqin; Sui, Zhihua

Agent Shelston IP

Pub. Number AU-B-2007217095

PCT Pub. Number WO2007/098382

Priority 60/775,043 17.02.06 US

Filing date 16 February 2007

Wipo publication date 30 August 2007

Acceptance publication date 3 May 2012

International Classifications

C07J 51/00 (2006.01) Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

A61P 5/46 (2006.01) Drugs for disorders of the endocrine system

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/098382 Priority application(s): WO2007/098382

3 May 2012 Application Accepted

  Published as AU-B-2007217095

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217097-Tetracyclic steroid derivatives useful as progesterone receptor modulators

2007217094-11-phosphorous steroid derivatives useful as progesterone receptor modulators